Skip to content
★ Sign in to follow
DA

David Aviezer

CEO
Protalix BioTherapeutics, Inc.
Total declarations
24
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (13 ops.)
€4.5M

Latest filing published 18 Jul 2012 for Protalix BioTherapeutics, Inc..

Insider track record

Disclosed buys
0
Disclosed sells
13
Signal history

No signal scores available.

David Aviezer: trading record in brief

David Aviezer is a declared insider of Protalix BioTherapeutics, Inc., with filings sourced from SEC (Form 4). We count 24 filings; the first trade dates from 16 April 2009 and the latest from 16 July 2012.

Sales make up the whole of the open-market record (13 sales, €4.5M). Outside the open market, there are 5 share grants and 6 option exercises. In 2012 alone, the filings show no purchases and 1 sale.

The latest filing, published on 18 July 2012, reports a share grant in Protalix BioTherapeutics, Inc. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to David Aviezer

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations24 total

24 of 24 declarations